Literature DB >> 10930402

LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells.

V T Lee1, C Tam, O Schneewind.   

Abstract

Pathogenic Yersinia species employ type III machines to transport virulence factors across the bacterial envelope. Some substrates for the type III machinery are secreted into the extracellular medium, whereas others are targeted into the cytosol of host cells. We found that during infection of tissue culture cells, yersiniae secrete small amounts of LcrV into the extracellular medium. Knockout mutations of lcrV abolish Yersinia targeting and reduce expression of the lcrGVHyopBD operon. In contrast, a block in LcrV secretion does not affect targeting, but results in premature expression and secretion of Yop proteins into the extracellular medium. LcrV-mediated activation of the type III pathway is thought to occur by sequestration of the regulatory factor LcrG, presumably via the formation of LcrV.LcrG complexes. These results suggest that intrabacterial LcrV regulates the expression and targeting of Yop proteins during Yersinia infection, whereas secreted LcrV is required to ensure specificity of Yop injection into eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930402     DOI: 10.1074/jbc.M002467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis.

Authors:  J S Matson; M L Nilles
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

2.  Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.

Authors:  K L DeBord; V T Lee; O Schneewind
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

3.  The crystal structures of the Salmonella type III secretion system tip protein SipD in complex with deoxycholate and chenodeoxycholate.

Authors:  Srirupa Chatterjee; Dalian Zhong; Bryce A Nordhues; Kevin P Battaile; Scott Lovell; Roberto N De Guzman
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

4.  Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

Authors:  Kristin L DeBord; Deborah M Anderson; Melanie M Marketon; Katie A Overheim; R William DePaolo; Nancy A Ciletti; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Yersinia pestis IS1541 transposition provides for escape from plague immunity.

Authors:  Claire A Cornelius; Lauriane E Quenee; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

6.  The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a type III secretion pathway.

Authors:  Sarah E Burr; Katja Stuber; Joachim Frey
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

7.  Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.

Authors:  Teiji Sawa; Emi Ito; Vinh Huu Nguyen; Matthew Haight
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

9.  LcrV mutants that abolish Yersinia type III injectisome function.

Authors:  Katherine Given Ligtenberg; Nathan C Miller; Anthony Mitchell; Gregory V Plano; Olaf Schneewind
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

10.  YscU cleavage and the assembly of Yersinia type III secretion machine complexes.

Authors:  Kelly E Riordan; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2008-04-29       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.